Decreased nervonic acid levels in erythrocyte membranes predict psychosis in help-seeking ultra-high-risk individuals

Molecular Psychiatry

Volumn 17, Issue 12, 2012, Pages 1150-1152

  Amminger, G P ^a,b   Schafer M R ^a,b   Klier, C M ^b   Slavik, J M ^c   Holzer, I ^c   Holub, M ^c   Goldstone, S ^a   Whitford, T J ^a   McGorry, P D ^a   Berk, M ^a,d  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF VIENNA   (Austria)

^d DEAKIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

15 TETRACOSENOIC ACID; ACYL COENZYME A DESATURASE 1; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; LEUKOTRIENE; LINOLEOYL COENZYME A DESATURASE; MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID; PLACEBO; PROSTACYCLIN; THROMBOXANE; UNCLASSIFIED DRUG;

BIOTRANSFORMATION; BIPOLAR I DISORDER; CAPILLARY GAS CHROMATOGRAPHY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ERYTHROCYTE MEMBRANE; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; HELP SEEKING BEHAVIOR; HIGH RISK POPULATION; HUMAN; IMMUNE RESPONSE; LETTER; LIPID COMPOSITION; NERVE CELL MEMBRANE; POSITIVE AND NEGATIVE SYNDROME SCALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN FUNCTION; PSYCHOSIS; RISK REDUCTION; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER;

ADOLESCENT; BIOLOGICAL MARKERS; ERYTHROCYTE MEMBRANE; FATTY ACIDS, MONOUNSATURATED; HUMANS; PREDICTIVE VALUE OF TESTS; PSYCHOTIC DISORDERS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS;

EID: 84870065082     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2011.167     Document Type: Letter

References (13)

1. Bourre JM, Bonneil M, Chaudière J, Clément M, Dumont O, Durand G et al. Adv Exp Med Biol 1992; 318: 211-229.
2. Innis SM. Brain Res 2008; 1237: 35-43.
3. Babin F, Sarda P, Limasset B, Descomps B, Rieu D, Mendy F et al. Lipids 1993; 28: 627-630.
4. Berger GE, Smesny S, Amminger GP. Int Rev Psychiatry 2006; 18: 85-98.
5. Amminger GP, Schäfer MR, Papageorgiou K, Klier CM, Cotton SM, Harrigan SM et al. Arch Gen Psychiatry 2010; 67: 146-154.
6. Assies J, Lieverse R, Vreken P, Wanders RJ, Dingemans PM, Linszen DH. Biol Psychiatry 2001; 49: 510-522.
7. Yung AR, Phillips LJ, McGorry PD, McFarlane CA, Francey S, Harrigan S et al. Br J Psychiatry Suppl 1998; 172: 14-20.
8. Assies J, Pouwer F, Lok A, Mocking RJ, Bockting CL, Visser I et al PLoS ONE 2010; 5: e10635.
9. Bloemen OJN, de Koning MB, Schmitz N, Nieman DH, Becker HE, de Haan L et al. Psychol Med 2010; 40: 1297-1304.
10. Bartzokis G. Neuropsychopharmacology 2002; 27: 672-683.
11. Peters BD, Duran M, Vlieger EJ, Majoie CB, den Heeten GJ, Linszen DH et al. Prostaglandins Leukot Essent Fatty Acids 2009; 81: 61-63.
12. Oda E, Hatada K, Kimura J, Aizawa Y, Thanikachalam PV, Watanabe K. Int Heart J 2005; 46: 975-985.
13. Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M et al. Neurosci Biobehav Rev 2011; 35: 804-817.